McMillan Shakespeare
Market Cap
AU$1.2b
Last Updated
2019/11/22 10:30 UTC
Data Sources
Company Financials +
Executive Summary
McMillan Shakespeare Limited provides salary packaging, novated leasing, asset management, and related financial products and services in Australia, the United Kingdom, and New Zealand.
Snowflake
Fundamentals
Excellent balance sheet with proven track record.
Share Price & News
How has McMillan Shakespeare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MMS has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-2.2%
MMS
-0.3%
AU Professional Services
-1.0%
AU Market
1 Year Return
16.4%
MMS
21.6%
AU Professional Services
16.2%
AU Market
Return vs Industry: MMS underperformed the Australian Professional Services industry which returned 21.6% over the past year.
Return vs Market: MMS matched the Australian Market which returned 16.2% over the past year.
Shareholder returns
| MMS | Industry | Market | |
|---|---|---|---|
| 7 Day | -2.2% | -0.3% | -1.0% |
| 30 Day | 7.5% | 2.6% | -0.2% |
| 90 Day | -0.4% | 5.3% | 2.2% |
| 1 Year | 22.7%16.4% | 25.2%21.6% | 21.9%16.2% |
| 3 Year | 83.7%59.4% | 45.2%33.9% | 36.3%17.7% |
| 5 Year | 94.1%53.5% | 50.9%30.6% | 52.7%18.3% |
Price Volatility Vs. Market
How volatile is McMillan Shakespeare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 days ago | Simply Wall St
What Percentage Of McMillan Shakespeare Limited (ASX:MMS) Shares Do Insiders Own?2 weeks ago | Simply Wall St
What McMillan Shakespeare Limited's (ASX:MMS) ROE Can Tell Us3 weeks ago | Simply Wall St
Here's Why McMillan Shakespeare (ASX:MMS) Can Manage Its Debt ResponsiblyValuation
Is McMillan Shakespeare undervalued compared to its fair value and its price relative to the market?
20.72x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: MMS (A$15.96) is trading above our estimate of fair value (A$13.89)
Significantly Below Fair Value: MMS is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MMS is good value based on its PE Ratio (20.7x) compared to the Professional Services industry average (20.9x).
PE vs Market: MMS is poor value based on its PE Ratio (20.7x) compared to the Australian market (18.7x).
Price to Earnings Growth Ratio
PEG Ratio: MMS is poor value based on its PEG Ratio (1.2x)
Price to Book Ratio
PB vs Industry: MMS is overvalued based on its PB Ratio (3.6x) compared to the AU Professional Services industry average (2.1x).
Next Steps
Future Growth
How is McMillan Shakespeare forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
17.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MMS's forecast earnings growth (17.5% per year) is above the savings rate (2.3%).
Earnings vs Market: MMS's earnings (17.5% per year) are forecast to grow faster than the Australian market (9.6% per year).
High Growth Earnings: MMS's earnings are forecast to grow, but not significantly.
Revenue vs Market: MMS's revenue (3.3% per year) is forecast to grow slower than the Australian market (3.6% per year).
High Growth Revenue: MMS's revenue (3.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MMS's Return on Equity is forecast to be high in 3 years time (27.1%)
Next Steps
Past Performance
How has McMillan Shakespeare performed over the past 5 years?
-4.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MMS has high quality earnings.
Growing Profit Margin: MMS's current net profit margins (11.6%) are higher than last year (9.2%).
Past Earnings Growth Analysis
Earnings Trend: MMS's earnings have declined by -4% per year over the past 5 years.
Accelerating Growth: MMS's earnings growth over the past year (26.6%) exceeds its 5-year average (-4% per year).
Earnings vs Industry: MMS earnings growth over the past year (26.6%) exceeded the Professional Services industry 22.2%.
Return on Equity
High ROE: MMS's Return on Equity (17.2%) is considered low.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is McMillan Shakespeare's financial position?
Financial Position Analysis
Short Term Liabilities: MMS's short term assets (A$351.5M) exceeds its short term liabilities (A$142.1M)
Long Term Liabilities: MMS's short term assets (A$351.5M) exceeds its long term liabilities (340.1M)
Debt to Equity History and Analysis
Debt Level: MMS's debt to equity ratio (88.7%) is considered high.
Reducing Debt: MMS's debt to equity ratio has reduced from 96.1% to 88.7% over the past 5 years.
Debt Coverage: MMS's debt is well covered by operating cash flow (40.3%).
Interest Coverage: MMS's interest payments on its debt are well covered by EBIT (12.1x coverage).
Balance Sheet
Inventory Level: MMS has a high level of physical assets or inventory.
Debt Coverage by Assets: MMS's debt is covered by short term assets (assets are 1.1x debt).
Next Steps
Dividend
What is McMillan Shakespeare's current dividend yield, its reliability and sustainability?
4.64%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: MMS's dividend (4.64%) is higher than the bottom 25% of dividend payers in the Australian market (2.38%).
High Dividend: MMS's dividend (4.64%) is low compared to the top 25% of dividend payers in the Australian market (5.58%).
Stability and Growth of Payments
Stable Dividend: MMS's dividend payments have been volatile in the past 10 years.
Growing Dividend: MMS's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (96.1%), MMS's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: MMS's dividends in 3 years are forecast to be covered by earnings (61.4% payout ratio).
Next Steps
Management
What is the CEO of McMillan Shakespeare's salary, the management and board of directors tenure and is there insider trading?
3.5yrs
Average management tenure
CEO
Mike Salisbury 0
5.1yrs
Tenure
AU$787,874
Compensation
Mr. Michael Neil Salisbury, also known as Mike, MBA has been the Chief Executive Officer of McMillan Shakespeare Ltd. since October 1, 2014 and has been its Managing Director since February 5, 2015. Mr. Sa ...
CEO Compensation Analysis
Compensation vs Market: Mike's total compensation ($USD534.99K) is below average for companies of similar size in the Australian market ($USD996.13K).
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
Management Age and Tenure
3.5yrs
Average Tenure
Experienced Management: MMS's management team is considered experienced (3.5 years average tenure).
Board Age and Tenure
5.5yrs
Average Tenure
57.5yo
Average Age
Experienced Board: MMS's board of directors are considered experienced (5.5 years average tenure).
Insider Trading
Insider Buying: MMS insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Company |
| Shares | 742,581 |
| Max Price | AU$4.68 |
| Entity | Company |
| Shares | 919,876 |
| Max Price | AU$15.35 |
| Entity | Company |
| Shares | 43,838 |
| Max Price | AU$16.04 |
| Entity | Company |
| Shares | 101,830 |
| Max Price | AU$16.05 |
| Entity | Company |
| Shares | 63,101 |
| Max Price | AU$16.14 |
| Entity | Company |
| Shares | 1,161,923 |
| Max Price | AU$16.20 |
| Entity | Company |
| Shares | 355,922 |
| Max Price | AU$16.02 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Non-Executive Director |
| Shares | 1,254 |
| Max Price | AU$15.94 |
| Entity | Individual |
| Role | Chief Executive Officer MD, CEO & Director |
| Shares | 6,250 |
| Max Price | AU$15.82 |
| Entity | Company |
| Shares | 1,015,812 |
| Max Price | AU$17.35 |
| Entity | Company |
| Shares | 1,851,314 |
| Max Price | AU$17.94 |
| Entity | Company |
| Shares | 45,661 |
| Max Price | AU$12.19 |
| Entity | Company |
| Shares | 42,673 |
| Max Price | AU$12.11 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Non-Executive Director |
| Shares | 11,000 |
| Max Price | AU$12.11 |
| Entity | Individual |
| Role | Chairman of the Board Non-Executive Chairman |
| Shares | 11,000 |
| Max Price | AU$12.05 |
| Entity | Company |
| Shares | 1,293,581 |
| Max Price | AU$13.38 |
| Entity | Company |
| Shares | 1,226,518 |
| Max Price | AU$13.19 |
| Entity | Company |
| Shares | 596,747 |
| Max Price | AU$12.89 |
| Entity | Company |
| Shares | 346,809 |
| Max Price | AU$17.76 |
| Entity | Company |
| Shares | 2,858,121 |
| Max Price | AU$16.15 |
| Entity | Company |
| Shares | 111,376 |
| Max Price | AU$14.31 |
| Entity | Company |
| Shares | 15,922 |
| Max Price | AU$14.36 |
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Management Team
Mark Blackburn
CFO & Company Secretary
- Tenure: 8.1yrs
- Compensation: AU$643.42k
Geoff Kruyt
Managing Director of Maxxia UK
- Tenure: 0yrs
- Compensation: AU$911.97k
Mike Salisbury
MD, CEO & Director
- Tenure: 5.1yrs
- Compensation: AU$787.87k
Andrew Suckling
Group Executive of Innovation
- Tenure: 0yrs
- Compensation: AU$213.80k
Sean Dempsey
Chief Executive Officer of Plan Management Partners
- Tenure: 0yrs
Suzanne Shepherd
Group Executive of Human Resources
- Tenure: 0yrs
Ron Steiner
Group Executive of Customer Relations
- Tenure: 2yrs
Simon Haidar
Group Executive of Sales & Product Services
- Tenure: 0yrs
Julia Edwards-Smith
Group Executive of Marketing
- Tenure: 0.8yrs
Board Members
Ian Elliot (65yo)
Independent Non-Executive Director
- Tenure: 5.5yrs
- Compensation: AU$133.75k
John Bennetts (56yo)
Non-Executive Director
- Tenure: 15.9yrs
- Compensation: AU$124.38k
Ross Chessari (59yo)
Non-Executive Director
- Tenure: 15.9yrs
- Compensation: AU$122.50k
Tim Poole (50yo)
Non-Executive Chairman
- Tenure: 4.1yrs
- Compensation: AU$208.84k
Helen Kurincic
Independent Non-Executive Director
- Tenure: 1.2yrs
- Compensation: AU$108.85k
Mike Salisbury
MD, CEO & Director
- Tenure: 5.1yrs
- Compensation: AU$787.87k
Company Information
McMillan Shakespeare Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: McMillan Shakespeare Limited
- Ticker: MMS
- Exchange: ASX
- Founded: 1988
- Industry: Human Resource and Employment Services
- Sector: Commercial Services
- Market Cap: AU$1.226b
- Shares outstanding: 76.84m
- Website: https://www.mmsg.com.au
Number of Employees
Location
- McMillan Shakespeare Limited
- The Tower
- Level 21
- Melbourne
- Victoria
- 3000
- Australia
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| MMS | ASX (Australian Securities Exchange) | Yes | Ordinary Shares | AU | AUD | Mar 2004 |
| MCSL.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Mar 2004 |
| MMS | CHIA (Chi-X Australia) | Yes | Ordinary Shares | AU | AUD | Mar 2004 |
| NMN | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Mar 2004 |
Biography
McMillan Shakespeare Limited provides salary packaging, novated leasing, asset management, and related financial products and services in Australia, the United Kingdom, and New Zealand. It operates in thre ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/11/22 10:30 |
| End of Day Share Price | 2019/11/22 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2019/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.